Cardiovascular risk factors in children and adolescents with congenital adrenal hyperplasia due to 21‐hydroxylase deficiency

Abstract

Despite a reduction in steroid doses over the last decade, a number of children with CAH are still obese and hypertensive. Whether this reflects general population trends or indicates a need to further optimize treatment regimens remains to be determined.